Ca2+/Calmodulin directly interacts with the pleckstrin homology domain of AKT1

被引:38
作者
Dong, Biao
Valencia, C. Alexander
Liu, Rihe
机构
[1] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA
关键词
D O I
10.1074/jbc.M702123200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AKT kinase, also known as protein kinase B, is a key regulator of cell growth, proliferation, and metabolism. The activation of the AKT signaling pathway is one of the most frequent molecular alterations in a wide variety of human cancers. Dickson and coworkers recently observed that Ca2(+) center dot calmodulin ( Ca2(+) center dot CaM) may be a common regulator of AKT1 activation ( Deb, T. B., Coticchia, C. M., and Dickson, R. B. ( 2004) J. Biol. Chem. 279, 38903 - 38911). In our efforts to scan the mRNA-displayed proteome libraries for Ca2(+) center dot CaM- binding proteins, we found that both human and Caenorhabditis elegans AKT1 kinases bound to CaM in a Ca2(+)- dependent manner ( Shen, X., Valencia, C. A., Szostak, J., Dong, B., and Liu, R. ( 2005) Proc. Natl. Acad. Sci. U. S. A. 102, 5969 - 5974 and Shen, X., Valencia, C. A., Gao, W., Cotten, S. W., Dong, B., Chen, M., and Liu, R. ( 2007) submitted for publication). Here we demonstrate that Ca2 (+)center dot CaM and human AKT1 were efficiently co-immunoprecipitated, and their interaction was direct rather than mediated by other proteins. The binding is in part attributed to the first 42 residues of the pleckstrin homology ( PH) domain, a region that is critical for the recognition of its lipid ligands. The PH domain of human AKT1 can disrupt the complex of the full-length AKT1 with Ca2 (+) center dot CaM. In addition, Ca2(+) center dot CaM competes with phosphatidylinositol 3,4,5- trisphophate for interaction with the PH domain of human AKT1. Our findings suggest that Ca2(+) center dot CaM is directly involved in regulating the functions of AKT1, presumably by releasing the activated AKT1 from the plasma membrane and/ or prohibiting it from re-association with phosphoinositides on plasma membrane.
引用
收藏
页码:25131 / 25140
页数:10
相关论文
共 60 条
[1]   Perturbations of the AKT signaling pathway in human cancer [J].
Altomare, DA ;
Testa, JR .
ONCOGENE, 2005, 24 (50) :7455-7464
[2]   Role of translocation in the activation and function of protein kinase B [J].
Andjelkovic, M ;
Alessi, DR ;
Meier, R ;
Fernandez, A ;
Lamb, NJC ;
Frech, M ;
Cron, P ;
Cohen, P ;
Lucocq, JM ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) :31515-31524
[3]   Solution structure and backbone dynamics of the pleckstrin homology domain of the human protein kinase B (PKB/Akt).: Interaction with inositol phosphates [J].
Auguin, D ;
Barthe, P ;
Augé-Sénégas, MT ;
Stern, MH ;
Noguchi, M ;
Roumestand, C .
JOURNAL OF BIOMOLECULAR NMR, 2004, 28 (02) :137-155
[4]   Activation of AKT kinases in cancer: Implications for therapeutic targeting [J].
Bellacosa, A ;
Kumar, CC ;
Di Cristofano, A ;
Testa, JR .
ADVANCES IN CANCER RESEARCH, VOL 94, 2005, 94 :29-+
[5]   A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION [J].
BELLACOSA, A ;
TESTA, JR ;
STAAL, SP ;
TSICHLIS, PN .
SCIENCE, 1991, 254 (5029) :274-277
[6]   Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1 [J].
Biggs, WH ;
Meisenhelder, J ;
Hunter, T ;
Cavenee, WK ;
Arden, KC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7421-7426
[7]   Lost in translation: Dysregulation of cap-dependent translation and cancer [J].
Bjornsti, MA ;
Houghton, PJ .
CANCER CELL, 2004, 5 (06) :519-523
[8]   Advances in protein kinase B signalling:: AKTion on multiple fronts [J].
Brazil, DP ;
Yang, ZZ ;
Hemmings, BA .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (05) :233-242
[9]   Ten years of protein kinase B signalling: a hard Akt to follow [J].
Brazil, DP ;
Hemmings, BA .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (11) :657-664
[10]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868